2024 MedTech Innovator Asia Pacific Live

About MedTech Innovator LIVE

Webinars are one hour in length and are live-streamed on our YouTube Channel. They will also be recorded and available for later viewing.

The goal of the MedTech Innovator webinars is to provide the medtech ecosystem and our portfolio companies with feedback from experts and professionals in areas that are specific to the strategic needs outlined in our discussions and surveys. Strategic areas to be covered include: intellectual property, product development, commercialization, reimbursement, healthcare economics, regulatory strategy, clinical trial design and execution, and fundraising.

Our webinars are administered virtually and consist of one or more panelists addressing key questions supplied in advance by the MedTech Innovator Asia Pacific Accelerator & Showcase companies, as well as a general discussion on the topic within the context of the evolving healthcare ecosystem.

2024 Upcoming Webinars


Webinar 1 – Perfecting your pitch

4 July, 2024, 10:00 AM Singapore Time (GMT+8)

Sachin Dubey, Module Innovations

Sachin is a Nanotechnologist and a med-tech innovator with experience in developing diagnostics for human diseases. He is the Co-Founder and CEO of Module Innovations working on precision diagnostics for infectious diseases and Anti-Microbial
Resistance (AMR). He has been the project leader for several healthcare Innovation projects funded by DST-GoI, DBT-GoI,
BIRAC, Nesta-UK, BMGF, Grand Challenges Canada (GCC), Titan, Tata Trusts and CARB-X, USA. As active innovator Sachin holds
several patents on technologies in healthcare innovations. Sachin was accorded as top 10 Innovators of India by India Innovations
Growth Program (IIGP 2.0) in 2017. With a B.Tech and M.Tech in Nanotechnology, Sachin is a Chevening CRISP Fellow from the
University of Oxford, UK.

Jim West, BioTools Innovator

Jim is an engineer turned entrepreneur. With a master’s in both Biomedical Engineering Product Development and Entrepreneurship, he blends the business with the technical. Jim previously worked in life sciences and medical devices helping to bring new products to market. He served as Co-Founder and CEO of his most recent company, Clara Biotech, which was founded in 2018 and was acquired by Innovaprep in the summer of 2023.

Webinar 2 – Fundraising, Term Sheets & Deal Structuring

11 July, 2024, 10:00 AM Singapore Time (GMT+8)

Dr Joseph Mocanu, Verge HealthTech Funding

Joseph is a co-founder and Managing Partner of Verge HealthTech Fund focusing on early-stage healthcare technology companies that make an impact on global health. Prior to this, Joseph was a scientist researching new cancer therapies, a medical device entrepreneur, and a management consultant for Oliver Wyman where he led life sciences and digital health across Asia. He has 19 scientific publications, 3 patents, and has made investments in 29 healthcare technology companies to date.

Joseph has a PhD from the University of Toronto, and an MBA from the Richard Ivey School of Business.

Patrick O'Neill, MedTech Advantage Fund

Venture Investor who is passionate about finding ways to help entrepreneurs succeed. Extensive investment experience focused on early-stage companies in the medtech and climate tech sectors as lead investor and board member. Experienced in sourcing, investing and mentoring startups across the venture ecosystem from formation to exit. Core competencies in private company governance, strategic planning, and portfolio management.


Webinar 3 – Corporate Partnerships and M&A

18 July 2024, 10:00 AM Singapore Time (GMT+8)

Ashley Wittorf, Johnson & Johnson Medtech

Ashley Wittorf is responsible for sparking collaborations with groundbreaking healthcare companies and institutions across Asia Pacific as the regional business development lead for Johnson & Johnson MedTech. Ashley joined Johnson & Johnson in August of 2021 following an extensive career in the medical device industry. In her previous role, Ashley was a resident operating partner for medical device private equity firm Revival Healthcare Capital. Prior to Revival, Ashley spent more than eight years at the Advanced Medical Technology Association (AdvaMed) where she served as executive director of AdvaMed Accel; in this role, she was responsible for the creation and management of a new division focused on emerging-growth medical technology companies. While at AdvaMed, Ashley also managed the association’s relationships with the broader investment community from angel investors to Wall Street’s top equity analysts. Prior to joining AdvaMed, Ashley spent nearly ten years working in the MedTech and pharmaceutical industries with roles in product development, operations, marketing, and business development and strategy for both small, venture-backed enterprises and for large corporations, including Eli Lilly and Medtronic. Bringing her seasoned expertise in MedTech innovation, Ashley has served in several advisory capacities, including on the board of MedTech Innovator and through U.S. government-related initiatives including FDA’s CDRH Entrepreneurs-in-Residence Program and the NIH HEAL Partnership Committee. Ashley holds a master’s degree in bioengineering and a bachelor’s degree in mechanical engineering from the Georgia Institute of Technology. She also holds an MBA from the University of Virginia’s Darden School of Business. She currently resides in Singapore with her husband and two daughters.

Felicia Chung, Olympus Corporation

Felicia leads Olympus’ business development efforts for APAC and China regions, as well as Global Urology and Single-Use.

This includes identifying strategic opportunities for Olympus that drive complementary and/or innovative growth within the exciting Medtech space.

Under Felicia’s thought leadership, she initiated, lead and announced Olympus’ first ever APAC Innovation Program (“OAIP”) which was launched out of the APAC region.

The Program aims support the innovation ecosystem, identify and collaborate with Visionaries in this part of the world. Felicia sees APAC and China as very promising regions comprising of a hotbed of innovative and bold ideas, especially in the fields of digital and AI solutions.

Prior to joining Olympus, Felicia served in similar corporate development positions with other Corporates (Linde AG and Cargill, Inc.), executing M&A transactions from 2016 to 2021.

This follows her prior experience and interest in M&A transaction execution, which saw her career commencing at Citi Investment Banking in 2008 and subsequently Deutsche Bank in 2014.


Webinar 4 – Building an IP Portfolio in Medtech and Digital Health

1 August 2024, 10:00 AM Singapore Time (GMT+8)

TBD


Webinar 5 – Regulatory Strategy: APAC vs U.S.

8 August 2024, 10:00 AM Singapore Time (GMT+8)

TBD


Webinar 6 – PR & Brand Management

15 August 2024, 10:00 AM Singapore Time (GMT+8)

TBD


Webinar 7 – Attracting Talent and Building Effective MedTech Advisory Boards

29 August 2024, 10:00 AM Singapore Time (GMT+8)

TBD


Webinar 8 – Pricing, Reimbursement & Health Economics

12 September 2024, 10:00 AM Singapore Time (GMT+8)

TBD


Webinar 9 – Clinical Trials & Hospital Pilots

19 September 2024, 10:00 AM Singapore Time (GMT+8)

TBD


Webinar 10 – Commercialization: Building & Managing Distribution Channels in APAC vs U.S.

26 September 2024, 10:00 AM Singapore Time (GMT+8)

TBD

2024 Webinar Recordings

2024 Schedule

All webinars begin at 10:00 AM Singapore Time (GMT+8), unless otherwise noted.
Date Topic
JUL 4 Perfecting Your Pitch Video
JUL 11 Fundraising, Term Sheets & Deal Structuring
JUL 18 Corporate Partnerships and M&A
AUG 1 Building an IP Portfolio in Medtech and Digital Health
AUG 8 Regulatory Strategy: APAC vs U.S.
AUG 15 PR & Brand Management
AUG 29 Attracting Talent and Building Effective MedTech Advisory Boards
SEPT 12 Pricing, Reimbursement & Health Economics
SEPT 19 Clinical Trials & Hospital Pilots
SEPT 26 Commercialization: Building & Managing Distribution Channels in APAC vs U.S.